Interstitial Lung Disease Study

Interstitial Lung Disease (ILD) is a group of lung diseases that affects the tissues and spaces around the air sacs of the lung and may occur when an injury to the lungs triggers an abnormal healing response. Ordinarily, the body generates just the right amount of inflammation to protect the body and repair the damage, but in ILD, the inflammation and repair process goes awry and the tissue around the air sacs becomes scarred and thickened, a process called fibrosis. This makes it more difficult for oxygen to pass into the bloodstream and sufferers often experience shortness of breath or coughing.

We are evaluating the safety and tolerability of an experimental new drug being developed to investigate a potential treatment for people with inflammatory and degenerative diseases.

If you meet the criteria for this study and would like more information, register below or call 1800 727 874.

– A healthy male or healthy female who is not pregnant and who is using highly effective contraception.
– Aged 18-65 (inclusive)
– Body weight 100Kg or less
– Body Mass Index (BMI) >18 and < 30 kg/m2